API and drug product CDMO reports rapid growth in MAH programs in China

Since the MAH pilot launch, the company has undertaken eight development programs.

Read more 

Bluebird Bio's acquires manufacturing facility to produce lentiviral vectors

Company executing long-term strategy to develop broad manufacturing capabilities for both vector supply and drug product supply to support clinical development and commercialization across pipeline.

Read more 

Featured suppliers

Browse all suppliers 

Latest products

Browse all products